Brent Ahrens
InvestorFounderGeneral Partner at Canaan Partners · Board director at Transposon Therapeutics · Board director at Unchained Labs · Board director at Minimally Invasive Devices
Menlo Park, California
Writes $250K – $20M checks · typically $10M
FoundedEndoGastric SolutionsMinimally Invasive DevicesRelievant MedsystemsTransposon TherapeuticsUnchained Labs
About
Brent Ahrens, a longtime West Coast healthcare lead since 1999, uniquely combines deep biopharma and medtech investing with a Kauffman Fellows background and active mentorship of new VCs.
Invests in
BiotechConsumerDeep TechEnterprise SoftwareFintechHardwareHealthtechMedical Devices
Board director at Transposon Therapeutics
Intro paths
In turn, Brent can intro founders to Transposon Therapeutics's investors below.
Transposon Therapeutics's investors · 1
Co-founders at Transposon Therapeutics

Board director at Unchained Labs
Intro paths
In turn, Brent can intro founders to Unchained Labs's investors below.
Unchained Labs's investors · 3
Co-founders at Unchained Labs
Board director at Minimally Invasive Devices
Intro paths
In turn, Brent can intro founders to Minimally Invasive Devices's investors below.
Minimally Invasive Devices's investors · 1
Co-founders at Minimally Invasive Devices
Experience
- Canaan PartnersGeneral Partnercurrent2005 — presentSan Francisco Bay Area
- Canaan PartnersPrincipal1999 — 2004Menlo Park/SF
- GSIDirector Business Development and Marketing1997 — 1999Cupertino, CA
- Johnson & JohnsonEngineer1991 — 1995Cincinnati Metropolitan Area
- IAP ResearchEngineer1986 — 1991Dayton Metropolitan Area
Education
- The Tuck School of Business at DartmouthMaster of Business Administration - MBA, Finance1995 — 1997
- University of DaytonMaster's degree, Mechanical Engineering1985 — 1986
- University of DaytonBachelor's degree, Mechanical Engineering1981 — 1985
Deals · 5
Transposon TherapeuticsBoard seat
via Canaan Partners · filed Dec 2020 · $45.2M raise
Minimally Invasive DevicesBoard seat
via Canaan Partners · filed Nov 2015 · $14.1M raise
Unchained LabsBoard seat
via Canaan Partners · filed Jun 2015 · $31M raise
EndoGastric SolutionsBoard seat
via Canaan Partners · filed Apr 2015 · $1.5M raise
Relievant MedsystemsBoard seat
via Canaan Partners · filed Feb 2015 · $5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Canaan Partners
Network4
Investors connected to Brent in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Brent Ahrens work?
- Brent Ahrens is General Partner at Canaan Partners and Founder at Transposon Therapeutics and Founder at Unchained Labs and Founder at Minimally Invasive Devices.
- What does Brent Ahrens invest in?
- Brent Ahrens invests in Biotech, Consumer, Deep Tech, Enterprise Software, Fintech, Hardware, Healthtech, Medical Devices.
- What check size does Brent Ahrens write?
- Brent Ahrens typically writes checks of $250K – $20M.
- What companies did Brent Ahrens found?
- Brent Ahrens founded EndoGastric Solutions, Minimally Invasive Devices, Relievant Medsystems, Transposon Therapeutics, Unchained Labs.
Same school
Also attended The Tuck School of Business at Dartmouth171
+ 165 more
Also attended University of Dayton20
+ 14 more
Shared employers
Also worked at Canaan Partners41
+ 35 more
Also worked at Johnson & Johnson144
+ 138 more




%20copy.jpg)



























